Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLuca, C.
Right arrow Articles by Hiscott, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeLuca, C.
Right arrow Articles by Hiscott, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 19, 13010-13016, May 7, 1999

Nuclear Ikappa Bbeta Maintains Persistent NF-kappa B Activation in HIV-1-infected Myeloid Cells

Carmela DeLucaDagger §, Louisa PetropoulosDagger parallel , Dana ZmeureanuDagger , and John HiscottDagger §parallel **

From the Dagger  Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital and the Departments of parallel  Microbiology & Immunology and § Medicine and the ** McGill AIDS Centre, McGill University, Montreal, Quebec H3T 1E2, Canada

Monocytic cells exhibit constitutive NF-kappa B activation upon infection with human immunodeficiency virus-1 (HIV-1). Because Ikappa Bbeta has been implicated in maintaining NF-kappa B·DNA binding, we sought to investigate whether Ikappa Bbeta was involved in maintaining persistent NF-kappa B activation in HIV-1-infected monocytic cell lines. Ikappa Bbeta was present in the nucleus of HIV-1-infected cells and participated in the ternary complex formation with NF-kappa B and DNA. In contrast to uninfected cells, the addition of recombinant glutathione S-transferase-Ikappa Balpha protein to preformed NF-kappa B·DNA complexes from HIV-1-infected cell extracts did not completely dissociate the complexes, suggesting that Ikappa Bbeta may protect NF-kappa B complexes from Ikappa Balpha -mediated dissociation. Immunodepletion of Ikappa Bbeta resulted in an NF-kappa B·DNA binding complex that was sensitive to Ikappa Balpha -mediated dissociation, thus demonstrating the protective role of Ikappa Bbeta . In addition, co-transfection studies with an NF-kappa B-dependent reporter construct demonstrated that Ikappa Bbeta co-expression partially alleviated inhibition of NF-kappa B-mediated gene expression by Ikappa Balpha , implying that Ikappa Bbeta can maintain transcriptionally active NF-kappa B·DNA complexes. Furthermore, constitutive phosphorylation of Ikappa Balpha was observed. Immunoprecipitation of the Ikappa B kinase (IKK) complex followed by in vitro analysis of kinase activity demonstrated that IKK was constitutively activated in HIV-1-infected myeloid cells. Thus, virus-induced constitutive IKK activation, coupled with the maintenance of a ternary NF-kappa B·DNA complex by Ikappa Bbeta , maintains persistent NF-kappa B activity in HIV-1-infected myeloid cells.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. M. Lindstrom, A. R. Mohan, M. R. Johnson, and P. R. Bennett
Histone Deacetylase Inhibitors Exert Time-Dependent Effects on Nuclear Factor-{kappa}B but Consistently Suppress the Expression of Proinflammatory Genes in Human Myometrial Cells
Mol. Pharmacol., July 1, 2008; 74(1): 109 - 121.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
L. A. Bruggeman
Viral Subversion Mechanisms in Chronic Kidney Disease Pathogenesis
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S13 - S19.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Nogalski, J. P. Podduturi, I. B. DeMeritt, L. E. Milford, and A. D. Yurochko
The Human Cytomegalovirus Virion Possesses an Activated Casein Kinase II That Allows for the Rapid Phosphorylation of the Inhibitor of NF-{kappa}B, I{kappa}B{alpha}
J. Virol., May 15, 2007; 81(10): 5305 - 5314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Xu, H. Bayat, X. Hou, and B. Jiang
Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-{kappa}B through phosphorylation of I{kappa}Bbeta
Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1336 - C1345.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T. M Lindstrom and P. R Bennett
The role of nuclear factor kappa B in human labour
Reproduction, November 1, 2005; 130(5): 569 - 581.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Hertlein, J. Wang, K. J. Ladner, N. Bakkar, and D. C. Guttridge
RelA/p65 Regulation of I{kappa}B{beta}
Mol. Cell. Biol., June 15, 2005; 25(12): 4956 - 4968.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Chen, S. Vallee, J. Wu, D. Vu, J. Sondek, and G. Ghosh
Inhibition of NF-{kappa}B Activity by I{kappa}B{beta} in Association with {kappa}B-Ras
Mol. Cell. Biol., April 1, 2004; 24(7): 3048 - 3056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Malek, D.-B. Huang, T. Huxford, S. Ghosh, and G. Ghosh
X-ray Crystal Structure of an I{kappa}B{beta}{middle dot}NF-{kappa}B p65 Homodimer Complex
J. Biol. Chem., June 13, 2003; 278(25): 23094 - 23100.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Chen, J. Wu, and G. Ghosh
{kappa}B-Ras Binds to the Unique Insert within the Ankyrin Repeat Domain of I{kappa}B{beta} and Regulates Cytoplasmic Retention of I{kappa}B{beta}{middle dot}NF-{kappa}B Complexes
J. Biol. Chem., June 13, 2003; 278(25): 23101 - 23106.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Lee, V. Allport, A. Sykes, T. Lindstrom, D. Slater, and P. Bennett
The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion
Mol. Hum. Reprod., April 1, 2003; 9(4): 213 - 218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Ladner, M. A. Caligiuri, and D. C. Guttridge
Tumor Necrosis Factor-regulated Biphasic Activation of NF-kappa B Is Required for Cytokine-induced Loss of Skeletal Muscle Gene Products
J. Biol. Chem., January 17, 2003; 278(4): 2294 - 2303.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Caamano and C. A. Hunter
NF-{kappa}B Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Clin. Microbiol. Rev., July 1, 2002; 15(3): 414 - 429.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
S. Kepinski and O. Leyser
Ubiquitination and Auxin Signaling: A Degrading Story
PLANT CELL, May 1, 2002; 14(90001): S81 - 95.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. T. Cowling, D. Gurantz, J. Peng, W. H. Dillmann, and B. H. Greenberg
Transcription Factor NF-kappa B Is Necessary for Up-regulation of Type 1 Angiotensin II Receptor mRNA in Rat Cardiac Fibroblasts Treated with Tumor Necrosis Factor-alpha or Interleukin-1beta
J. Biol. Chem., February 15, 2002; 277(8): 5719 - 5724.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
T. H. Mogensen and S. R. Paludan
Molecular Pathways in Virus-Induced Cytokine Production
Microbiol. Mol. Biol. Rev., March 1, 2001; 65(1): 131 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Bureau, S. Delhalle, G. Bonizzi, L. Fievez, S. Dogne, N. Kirschvink, A. Vanderplasschen, M.-P. Merville, V. Bours, and P. Lekeux
Mechanisms of Persistent NF-{kappa}B Activity in the Bronchi of an Animal Model of Asthma
J. Immunol., November 15, 2000; 165(10): 5822 - 5830.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Heylbroeck, S. Balachandran, M. J. Servant, C. DeLuca, G. N. Barber, R. Lin, and J. Hiscott
The IRF-3 Transcription Factor Mediates Sendai Virus-Induced Apoptosis
J. Virol., April 15, 2000; 74(8): 3781 - 3792.
[Abstract] [Full Text]


Home page
Sci SignalHome page
D. M. Rothwarf and M. Karin
The NF-{kappa}B Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus
Sci. Signal., October 26, 1999; 1999(5): re1 - re1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Poppers, P. Schwenger, and J. Vilcek
Persistent Tumor Necrosis Factor Signaling in Normal Human Fibroblasts Prevents the Complete Resynthesis of Ikappa B-alpha
J. Biol. Chem., September 15, 2000; 275(38): 29587 - 29593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bour, C. Perrin, H. Akari, and K. Strebel
The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-kappa B Activation by Interfering with beta TrCP-mediated Degradation of Ikappa B
J. Biol. Chem., May 4, 2001; 276(19): 15920 - 15928.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Stasiolek, V. Gavrilyuk, A. Sharp, P. Horvath, K. Selmaj, and D. L. Feinstein
Inhibitory and Stimulatory Effects of Lactacystin on Expression of Nitric Oxide Synthase Type 2 in Brain Glial Cells. THE ROLE OF Ikappa B-beta
J. Biol. Chem., August 4, 2000; 275(32): 24847 - 24856.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement